148 related articles for article (PubMed ID: 31187396)
1. Resection Combined with TKI Therapy for Resectable Liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China.
Chen Q; Li C; Yang H; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Cai J; Zhou J
J Gastrointest Surg; 2020 Jun; 24(6):1330-1341. PubMed ID: 31187396
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.
Chen Q; Li C; Yang H; Zhao H; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):317-323. PubMed ID: 30447909
[TBL] [Abstract][Full Text] [Related]
3. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
Turley RS; Peng PD; Reddy SK; Barbas AS; Geller DA; Marsh JW; Tsung A; Pawlik TM; Clary BM
Cancer; 2012 Jul; 118(14):3571-8. PubMed ID: 22086856
[TBL] [Abstract][Full Text] [Related]
4. The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study.
Wen H; Huang Y; Huang S; Xiao H; Xie W; Zhou Q; Tan L; Ding Y; Liu X; Yu Y; Song Z; Shen S; Chen Z; Zhang X
Int J Surg; 2024 Apr; 110(4):2151-2161. PubMed ID: 38619177
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
[TBL] [Abstract][Full Text] [Related]
6. Thermal ablation versus hepatic resection for the treatment of liver metastases from gastrointestinal stromal tumors: a retrospective study.
Yang DP; Zhuang BW; Wang YZ; Lin MX; Xu M; Kuang M; Lei YY; Xie XY; Xie XH
Int J Hyperthermia; 2020; 37(1):592-599. PubMed ID: 32484012
[No Abstract] [Full Text] [Related]
7. Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone.
Sutton TL; Walker BS; Billingsley KG; Sheppard BC; Corless CL; Heinrich MC; Mayo SC
HPB (Oxford); 2022 Jun; 24(6):986-993. PubMed ID: 34924291
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation vs. hepatectomy for liver metastases from gastrointestinal stromal tumors.
Zeng Y; Ling Y; Chen X; Ding C; Jin Y; Feng S; Chen Z; Guo J; Qiu H
Oncol Lett; 2024 Mar; 27(3):133. PubMed ID: 38362234
[TBL] [Abstract][Full Text] [Related]
9. Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy.
Qiu HB; Zhou ZG; Feng XY; Liu XC; Guo J; Ma MZ; Chen YB; Sun XW; Zhou ZW
Medicine (Baltimore); 2018 Jan; 97(2):e9097. PubMed ID: 29480823
[TBL] [Abstract][Full Text] [Related]
10. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
Cananzi FC; Belgaumkar A; Lorenzi B; Mudan S
ANZ J Surg; 2014 Dec; 84(12):937-42. PubMed ID: 25444423
[TBL] [Abstract][Full Text] [Related]
11. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
Cananzi FC; Belgaumkar AP; Lorenzi B; Mudan S
ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808
[TBL] [Abstract][Full Text] [Related]
12. Has the survival rate for surgically resected gastric gastrointestinal stromal tumors improved in the tyrosine kinase inhibitor era?
Pedroso FE; Raut CP; Xiao H; Yeo CJ; Koniaris LG
Ann Surg Oncol; 2012 Jun; 19(6):1748-58. PubMed ID: 22290567
[TBL] [Abstract][Full Text] [Related]
13. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
[TBL] [Abstract][Full Text] [Related]
14. Role of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry.
Sato S; Tsujinaka T; Masuzawa T; Yamamoto K; Takahashi T; Yamashita Y; Fujita J; Takagi M; Hirota S; Nishida T
Surg Today; 2017 Jan; 47(1):58-64. PubMed ID: 27194124
[TBL] [Abstract][Full Text] [Related]
15. Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months.
Lei C; Zhao B; Wang Q; Ge L; Wang H
J BUON; 2018; 23(2):460-467. PubMed ID: 29745093
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis.
Chen Y; Wei J; Cai J; Liu A
BMC Cancer; 2019 Aug; 19(1):793. PubMed ID: 31399067
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastases.
Tamura K; Yoshida T; Masuda K; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Horinouchi H; Yamamoto N; Ohe Y
ESMO Open; 2023 Aug; 8(4):101594. PubMed ID: 37517364
[TBL] [Abstract][Full Text] [Related]
19. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors.
Zaydfudim V; Okuno SH; Que FG; Nagorney DM; Donohue JH
J Surg Res; 2012 Oct; 177(2):248-54. PubMed ID: 22831567
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Stromal Tumours of the Rectum - Evaluating the National Registry Data with Respect to its Use in Clinical Practice.
Svatoň R; Kala Z; Kysela P; Procházka V; Eid M; Andrašina T; Poredská K; Strenková J; Chloupková R; Kunovsky L
Klin Onkol; 2019; 32(2):117-123. PubMed ID: 30995851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
